Search Results - Torsten Zimmermann

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial

    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial by Antonia M. Joussen, Sebastián Wolf, Peter K. Kaiser, David S. Boyer, Thomas Schmelter, Rupert Sandbrink, Oliver Zeitz, Gesa Deeg, Annett Richter, Torsten Zimmermann, Joachim Hoechel, Ulf Buetehorn, Walter Schmitt, Brigitte Stemper, Michael Karl Boettger

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 by Akihiro Takano, Fredrik Piehl, Jan Hillert, Andrea Varrone, Sangram Nag, Balázs Gulyás, Per Stenkrona, Victor L. Villemagne, Christopher C. Rowe, Richard Macdonell, Nabil Al Tawil, Thomas Kucinski, Torsten Zimmermann, Marcus Schultze‐Mosgau, Andrea Thiele, Anja Hoffmann, Christer Halldin

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: